Cargando…
Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)
BACKGROUND: Influenza virus (IV) infections are a major threat to human welfare and animal health worldwide. Anti-viral therapy includes vaccines and a few anti-viral drugs. However vaccines are not always available in time, as demonstrated by the emergence of the new 2009 H1N1-type pandemic strain...
Autores principales: | Pleschka, Stephan, Stein, Michael, Schoop, Roland, Hudson, James B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785784/ https://www.ncbi.nlm.nih.gov/pubmed/19912623 http://dx.doi.org/10.1186/1743-422X-6-197 |
Ejemplares similares
-
H1N1 pneumonia: our experience in 50 patients with a severe clinical course of novel swine-origin influenza A (H1N1) virus (S-OIV)
por: Valente, T., et al.
Publicado: (2011) -
The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens
por: Vergara-Alert, Júlia, et al.
Publicado: (2014) -
Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination
por: Lin, Hui-Tsu, et al.
Publicado: (2013) -
Echinacea purpurea
por: Lim, T. K.
Publicado: (2013) -
Comparative study of pandemic (H1N1) 2009, swine H1N1, and avian H3N2 influenza viral infections in quails
por: Thontiravong, Aunyaratana, et al.
Publicado: (2012)